- Report
- August 2026
- 160 Pages
Global
From €3107EUR$3,320USD£2,597GBP
€3884EUR$4,150USD£3,247GBP
- Report
- June 2026
- 116 Pages
Global
From €4352EUR$4,650USD£3,638GBP
- Report
- July 2025
- 150 Pages
Global
From €5569EUR$5,950USD£4,655GBP
- Report
- December 2024
- 150 Pages
Global
From €5569EUR$5,950USD£4,655GBP
- Report
- October 2023
- 145 Pages
Global
From €2948EUR$3,150USD£2,464GBP
- Report
- October 2023
- 145 Pages
Global
From €2948EUR$3,150USD£2,464GBP
- Report
- August 2025
- 120 Pages
United States
From €3697EUR$3,950USD£3,090GBP
- Report
- November 2023
- 189 Pages
Global
From €4212EUR$4,500USD£3,520GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €2340EUR$2,500USD£1,956GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1170EUR$1,250USD£978GBP
- Report
- December 2024
- 84 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- February 2024
- 168 Pages
Global
From €7441EUR$7,950USD£6,220GBP
- Report
- July 2023
- 135 Pages
Global
From €7020EUR$7,500USD£5,867GBP
- Report
- July 2023
- 67 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- May 2024
- 139 Pages
Global
From €3743EUR$3,999USD£3,129GBP
- Report
- January 2025
- 200 Pages
Global
From €4675EUR$4,995USD£3,908GBP
- Report
- February 2023
- 70 Pages
Global
From €3271EUR$3,495USD£2,734GBP
- Report
- November 2023
- 140 Pages
Global
From €4165EUR$4,450USD£3,481GBP
- Report
- October 2025
- 150 Pages
Global
From €4539EUR$4,850USD£3,794GBP
- Report
- June 2023
- 204 Pages
Global
From €3369EUR$3,600USD£2,816GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more